Background: Malaria has always been a serious infectious disease prevalent in the world. Antimalarial drugs such as chloroquine and artemisinin have been the main compounds used to treat malaria. However, the massive use of this type of drugs accelerates the evolution and spread of malaria parasites, leading to the development of resistance. A large number of related data have been published by researchers in recent years. CiteSpace software has gained popularity among us researchers in recent years, because of its ability to help us obtain the core information we want in a mass of articles. In order to analyze the hotspots and develop trends in this field through visual analysis, this study used CiteSpace software to summarize the available data in the literature to provide insights.Method: Relevant literature was collected from the Web of Science Core Collection (WOSCC) from 1 January 2015 to 29 March 2023. CiteSpace software and Microsoft Excel were used to analyze and present the data, respectively.Results: A total of 2,561 literatures were retrieved and 2,559 literatures were included in the analysis after the removal of duplicates. An irrefutable witness of the ever-growing interest in the topic of antimalarial drug resistance could be expressed by the exponentially increased number of publications and related citations from 2015 to 2022, and its sustained growth trend by 2023. During the past 7 years, USA, Oxford University, and David A Fidock are the country, institution, and author with the most publications in this field of research, respectively. We focused on the references and keywords from literature and found that the research and development of new drugs is the newest hotspot in this field. A growing number of scientists are devoted to finding new antimalarial drugs.Conclusion: This study is the first visual metrological analysis of antimalarial drug resistance, using bibliometric methods. As a baseline information, it is important to analyze research output published globally on antimalarial drug resistance. In order to better understand the current research situation and future research plan agenda, such baseline data are needed accordingly.
(1) Objective: Traditional Chinese medicine (TCM) plays an important role in the treatment of numerous illnesses. As a classic Chinese medicine, Wendan Decoction (WDD) encompasses a marvelous impact on the remedy of hyperlipidemia. It is known that hyperlipidemia leads to cardiovascular injury, therefore anti-vascular endothelial cell injury (AVECI) may be an underlying molecular mechanism of WDD in the cure of hyperlipidemia. However, there is no relevant research on the effect of WDD on vascular endothelial cells and its pharmacodynamic substances. Therefore, the purpose of this study was to investigate the protective effect of WDD on vascular endothelial cells. (2) Methods: The chemical constituents of WDD were determined by LC-MS/MS technology. The protective effects of 16 batches of WDD on samples from human umbilical vein endothelial cells (HUVECs) were evaluated. Finally, gray relation analysis (GRA) and partial least squares regression (PLSR) were used to analyze the potential correlation between chemical ingredients and AVECI. (3) Results: The results indicated that WDD had apparent protective effect on endothelial cells, and pharmacological properties in 16 batches of WDD tests were apparently discrepant. The GRA and PLSR showed that trigonelline, liquiritin, hesperidin, hesperetin, scopoletin, morin, quercetin, isoliquiritigenin, liquiritigenin and formononetin may be the active ingredients of AVECI in WDD. (4) Conclusions: WDD has a protective effect on endothelial cell injury induced by palmitic acid, which may be related to its component content. This method was suitable for the search of active components in classical TCM.
Neonatal hyperbilirubinemia is a disease found in newborns, and it can lead to permanent brain damage. Unconjugated hyperbilirubinemia could be treated by using various phototherapy techniques. This study sought to compare the mean duration of treatment required with light-emitting diode (LED) versus conventional phototherapy in newborns with unconjugated hyperbilirubinemia. The investigation included 452 patients, randomly distributed into two groups. LED phototherapies were administered to Group 1, while conventional phototherapy was administered to Group 2. Total serum bilirubin levels, along with unconjugated serum bilirubin levels, were checked at baseline. Once the serum total bilirubin level fell below the cutoff level, phototherapy was stopped. The total duration of phototherapy, in hours, along with other demographic data, was recorded and subsequently analyzed using a Student’s t-test. In Group 1, the mean gestational age was 37.51 ± 1.02 weeks, whereas in Group 2, it was 37.54 ± 1.02 weeks. The mean duration required for treatment with LED (Group 1) versus the conventional method of phototherapy (Group 2) in neonates with unconjugated jaundice was 36.26 ± 3.24 hours vs 45.5 ± 5.13 hours (p<0.0001), respectively. It was concluded that the mean duration required for the treatment of newborns affected by unconjugated hyperbilirubinemia was significantly lower with LED than with conventional phototherapy.
16 September 2026 in Journal of King Saud University – Science
Endothelial cells (ECs) form a selective barrier between blood vessels and surrounding tissues. They tightly regulate the passage of substances through blood vessels. ECs are crucial for regulating immunological responses, managing blood flow, and maintaining vascular stability. Disruption in endothelial cell function may lead to several complications, such as atherosclerosis, hypertension, and diabetic vascular issues. This review provides an in-depth analysis of endothelial cell biology, endothelial dysfunction-related disorders, and therapeutic approaches to address them. The role of ECs in maintaining vascular health, the core processes causing their dysfunction, and available strategies for endothelial cell repair and regeneration are emphasized through a comprehensive review of recent studies. The findings highlight the importance of early diagnosis and targeted therapy to prevent serious vascular complications and improve patient outcomes. The aim of this study is to serve as a useful resource for researchers and medical professionals seeking to enhance vascular health and develop novel treatments for endothelial-related disorders. GRAPHICAL